Torres G, Morales PE, Garca-Miguel M, Norambuena-Soto I, Cartes-Saavedra B, Vidal-Pea G, Moncada-Ruff D, Sanhueza-Olivares F, San Martn A, Chiong M
In some cases, no GLP-1 will be tolerable
GLp-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease
Sousa CA, Soares HM, Soares EV (2018) Nickel oxide (NiO) nanoparticles induce loss of cell viability in yeast mediated by oxidative stress
Semaglutide and tirzepatide are among the leading therapies currently being evaluated in obesity-related osteoarthritis research
This was later formulated as the drug exenatide (Byetta) [6]